Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SunWay Biotech CoROCO:1271 -4.39%90 FCF Margin % is 5.12% as of Dec. 2025, which is 57% below its 10-year median of 11.97. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, SunWay Biotech Co ranks better than 85.12% on this metric.
The historical rank and industry rank for SunWay Biotech Co's FCF Margin % or its related term are showing as below:
ROCO:1271'
s FCF Margin % Range Over the Past 10 Years
Min: 1.71 Med: 11.97 Max: 57.29
Current: 11.97
During the past 7 years, the highest FCF Margin % of SunWay Biotech Co was 57.29%. The lowest was 1.71%. And the median was 11.97%.
ROCO:1271's FCF Margin % is ranked better than 85.12% of 1955
companies
in the Consumer Packaged Goods industry
Industry Median: 2.15
vs ROCO:1271: 11.97
SunWay Biotech Co FCF Margin % Related Terms
SunWay Biotech Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for SunWay Biotech Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, SunWay Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SunWay Biotech Co FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SunWay Biotech Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where SunWay Biotech Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SunWay Biotech Co (ROCO:1271) has a FCF Margin % of 5.12% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on SunWay Biotech Co and its competitors. This is 57% below median its historical median of 11.97. Over the past decade, SunWay Biotech Co's FCF Margin % has ranged from 1.71 to 57.29. According to the industry distribution chart, SunWay Biotech Co ranks #291 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 14.9%.
Is SunWay Biotech Co's FCF Margin % too high?
SunWay Biotech Co's current FCF Margin % of 5.12% is 57% below median its 10-year median of 11.97. Over the past 10 years, this metric has ranged from a low of 1.71 to a high of 57.29. The Consumer Packaged Goods industry median FCF Margin % is 2.15. SunWay Biotech Co's value of 5.12% is 138.1% above this industry median. Based on the distribution chart, SunWay Biotech Co ranks #291 out of 1955 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's FCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, SunWay Biotech Co ranks #291 out of 1955 companies for FCF Margin %. This places SunWay Biotech Co in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.15. SunWay Biotech Co's value of 5.12% is 138.1% above this benchmark. Historically, SunWay Biotech Co's own FCF Margin % has ranged from 1.71 to 57.29 over the past decade. While the company's 10-year median is 11.97 vs. the industry median of 2.15, SunWay Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.15, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SunWay Biotech Co's current FCF Margin % of 5.12% is 138.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on SunWay Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SunWay Biotech Co's current FCF Margin % is 5.12%, which is 57% below median its own 10-year median of 11.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current FCF Margin % is 5.12%, which is 57% below median its 10-year median of 11.97 and 138.1% above the Consumer Packaged Goods industry median of 2.15. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current FCF Margin % is 5.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?
Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued.
The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11.
GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:1271:
FCF Margin %: 5.12% (57% below median its 10-year median of 11.97)
GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
Industry Position: 138.1% above the Consumer Packaged Goods median (#291 of 1955)
No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score
Get the complete analysis for ROCO:1271
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1271 has been successfully added to your 
